Skip to main content
Acta Cardiologica Sinica logoLink to Acta Cardiologica Sinica
. 2015 Nov;31(6):518–527. doi: 10.6515/ACS20150302A

Abnormalities of Selected Trace Elements in Patients with Coronary Artery Disease

Asim Ilyas 1, Munir H Shah 1
PMCID: PMC4804977  PMID: 27122917

Abstract

Background

Coronary artery diseases are multifactorial, and over the last several decades particular consideration and research have been devoted to investigating the imbalance of patient elemental levels. Our current study aimed to investigate the comparative distribution of Ca, Mg, Fe, Zn, Cu, Co, Mn, Cr, Cd and Pb in the blood of coronary artery disease patients and healthy subjects.

Methods

Blood samples collected from both groups were digested into a HNO3-HCLO4 (10:1 v/v) mixture in a microwave oven, followed by quantification of the elements by atomic absorption spectrometry.

Results

The average levels of Pb and Cr were markedly higher (p < 0.001) while those of Ca, Fe, Cu and Mn were moderately higher (p < 0.05) in blood of the patients compared to the controls. However, correlation study showed divergent relationships between various elements in the blood of both groups. Multivariate cluster analysis revealed two major clusters of the elements for patients: Ca-Mg-Mn-Co-Cd and Pb-Cu-Fe-Zn-Cr; whereas three common groups were observed for controls: Ca-Mg-Zn-Cu, Cr-Mn-Fe and Co-Cd-Pb. Variations in the elemental levels were also observed to be associated with gender, habitat, food and smoking habits of the subjects.

Conclusions

Overall, the distribution, correlation and apportionment of elemental data indicated an imbalance of the toxic/essential elements in blood of the patients compared to the controls.

Keywords: AAS, Blood, Cluster analysis, Coronary artery disease, Essential/toxic element

INTRODUCTION

The interaction between humans and trace elements may be described as a love-hate relationship. As the modern world has advanced, a variety of chemical compounds manufactured everyday, along with hazardous chemicals, especially toxic elements, are continuously emitted into the environment. This toxic element exposure may induce some serious ailments in humans, especially the development of coronary artery disease.1-4 Coronary artery disease can involve paroxysmal thoracic pain, often radiating to the arms, particularly the left, and is most often due to ischemia of the myocardium that arises when one or more of the heart’s arteries are narrowed or blocked by low density lipoprotein (LDL) and cholesterol-induced atherosclerosis.1,5 It is developed by oxidation of LDL molecules by free radicals, particularly reactive oxygen species. Normally, the cell possesses highly efficient protective mechanisms, including metal-binding proteins and antioxidants such as manganese superoxide dismutase, copper-zinc superoxide dismutase and iron containing enzyme catalase, which under normal conditions are designed to prevent the occurrence of free radical-induced injury.6,7

There always exists a dynamic balance among various elements in biological systems, which is responsible for many metabolic and physiological processes. Any disorder in the elemental balance is often related to some pathological condition, resulting in the eventual ailments described.8 Factors such as diet, absorption ability, toxicities and drug-nutrient interactions play a vital role in maintaining a balance of the elements in the body.9 The selected elements have been proposed to have diagnostic and prognostic value in ischemia heart disease, although there is no direct cause-effect relationship between the development of cardiovascular disease and the prevailing elements status.10

Various biological fluids have been used to evaluate the uptake and health effects of chemicals, especially toxic elements.11 Blood is a widely used specimen because it is the transport medium for the nutrients and elements to and from the tissues, and therefore provides rapid and reliable information about the element’s metabolism into the human body.12,13 Numerous studies have been reported in recent years regarding the essential and toxic element evaluation in the blood due to its natural significance and ease of sampling.14,15

The main objective of this study was to assess the disparities in the distribution, correlation and multivariate apportionment of selected trace elements (Ca, Mg, Fe, Zn, Cu, Co, Mn, Cr, Cd and Pb) in the blood of coronary artery disease patients in comparison with healthy subjects. Plausible associations of the blood elemental levels with gender, habitat, food and smoking habits of the subjects were also investigated. Knowledge about the essential and toxic element variations in healthy subjects and differences in coronary artery disease patients might help to elucidate the relationship of the elements to the disease and to decide whether these elements could be used as additional biochemical markers for the diagnosis and/or prognosis of the disease.

MATERIALS AND METHODS

Study population

A total of 80 coronary artery disease patients (newly diagnosed), between the ages of 36-65 years were included in this study, on a volunteer basis. Subjects were selected from the patients admitted in Punjab Institute of Cardiology, Lahore, Pakistan. Prior to the sample collection, the protocol of the study was approved by the hospital’s ethics committee and a signed, voluntary consent was obtained from each subject after being thoroughly briefed about the objectives of the study. Healthy donors (n = 79) were also selected on a volunteer basis from the same localities with matched age groups (between 35-66 years of age) and similar socioeconomic status (Table 1). A comprehensive intake form was filled out to record study subject information such as age, sex, residence, nature/duration of ailment, food habits, smoking habits and occupation at the time of sample collection from the subjects of both groups. The diagnosis of coronary artery disease (CAD) in patients had previously been established by a cardiology specialist, by analyzing the angiograms using customary procedures before blood was taken for biochemical assays. The presence of 1 or more stenoses = 50% in diameter of at least one major coronary artery was considered evidence of significant CAD in the patient.16,17

Table 1. Characteristics of the subjects .

Age (yrs) Gender Abode Food Habit Tobacco use
Range Mean Female Male Urban Rural Vegetarian Non-vegetarian No use Use
Coronary artery disease patients (n = 80) 36-65 49.8 31 (39%) 49 (61%) 56 (70%) 24 (30%) 51 (64%) 29 (36%) 35 (44%) 45 (56%)
Healthy donors (n = 79) 35-66 49.3 31 (40%) 48 (60%) 55 (70%) 24 (30%) 47 (59%) 32 (41%) 51 (65%) 28 (35%)
p-value NS NS NS NS NS NS NS NS 0.048 0.033

NS, non significant.

Sample collection and preparation

The blood samples were collected from an anticubital vein by using appropriate precautions to prevent exogenous contamination.18 The samples were immediately transferred to evacuated polyethylene tubes (venoject, 10 mL) and kept in a refrigerator until further processing.19 A precise and known amount of blood sample was transferred from the storage tube to the digestion flask and was treated with nitric acid-perchloric acid (10:1 v/v) mixture, with subsequent heating to a soft boil until white dense fumes were emitted. The digestion procedure was carried out in a microwave oven, whereafter the sample contents were then cooled down to room temperature and subsequently diluted to the appropriate volume with double distilled water.12,20 Blanks containing all the reagents in the same sequence were also processed in a similar manner with each batch of the samples and the relative contribution of the elements in blank was generally < 2%. All chemical reagents used during the present study were of analytical grade (certified purity > 99.99%) and procured from E-Merck, Darmstadt, Germany. Working standards of the elements were prepared by serial dilution of 1000 mg/L stock standard solutions, just before the instrumental analysis.

Quantification of the elements

Quantitative analysis of selected essential and toxic elements (Ca, Mg, Fe, Zn, Cu, Co, Mn, Cr, Cd and Pb) was carried out on flame atomic absorption spectrophotometer (Shimadzu AA-670, Kyoto, Japan) under optimum analytical conditions as mentioned in Table 2. Three sub-samples of each sample were treated and run separately onto the spectrophotometer to pool the mean concentrations. Parallel routine check on the accuracy of quantified results was ensured through the use of standard reference material (NIST SRM 1598a) which showed excellent recoveries as shown in Table 2. Some of the samples were also analysed at an independent laboratory for comparison of the results, and a maximum of 5% difference was observed in the results of the two laboratories.

Table 2. Optimum analytical conditions maintained on AAS for the analysis of selected elements using air-acetylene flame, blank contribution and certified Vs. measured elemental levels in standard reference material (NIST SRM 1598a) .

Ca Mg Fe Zn Cu Co Mn Cr Cd Pb
Wavelength (nm) 422.7 285.2 248.3 213.9 324.8 240.7 279.5 357.9 228.8 217.0
HC lamp current (mA) 6 4 8 4 3 6 5 5 4 7
Slit width (nm) 0.5 0.5 0.2 0.5 0.5 0.2 0.4 0.5 0.3 0.3
Fuel-gas flow rate (L/min.) 2.0 1.6 2.0 2.0 1.8 2.2 1.9 2.6 1.8 1.8
Blank contribution (%) 0.88 1.26 1.14 1.33 0.75 1.2 0.51 0.94 1.37 1.68
SRM certified level (μg/L) 96000 -- 1680 880 1580 1.24 1.78 0.33 0.048 --
SRM measured level (μg/L) 95700 -- 1672 885 1568 1.22 1.77 0.32 0.046 --
Recovery (%) 99.7 -- 99.5 100.6 99.2 98.4 99.4 97.0 95.8 --

Statistical analysis

Statistical analyses of the elemental data were performed by using STATISTICA software.21 Basic statistical parameters, such as, range, mean, median, standard deviation (SD) and skewness were computed, along with correlation analysis. In order to evaluate the statistically significant differences (at p < 0.05), the two sample t-test was employed for comparison of mean concentrations, while the Wilcoxon rank-sum test was used for the comparison of the median levels. Multivariate analysis in terms of cluster analysis (CA) was carried out for apportionment of the elements in blood samples of the patients and controls.22 CA involves grouping of the variables into clusters each of which is a combination of objects having similar characteristics, thus resulting in internal homogeneity and external heterogeneity. The purpose of CA is to discover a system of organizing observations where variables share properties in common. The variables are grouped in clusters in terms of their nearness or similarity which is based on the Pearson-r distance. Therefore, it is cognitively easier to predict mutual properties based on an overall group membership.

RESULTS AND DISCUSSION

Characteristics of the subjects

The demographic data related to the coronary artery disease patients and healthy subjects/controls, as shown in Table 1, revealed that the subjects in the two groups were closely matched for age (~49 years on the average) and the majority of them (70%) resided in urban areas. About 60% of the samples in both groups were collected from male donors. Sixty-four percent (64%) of cases in the patient group and 59% in the control group were vegetarian in their food habits. A majority of the patients (56%) were using tobacco on a continuous basis, in contrast to the healthy subjects (35%). All patients were newly diagnosed and were not under previous medications.

Distribution of the elements in the blood of coronary artery disease patients and controls

Basic statistical parameters related to the concentrations (μg/L) of Ca, Mg, Fe, Zn, Cu, Co, Mn, Cr, Cd and Pb in blood samples of coronary artery disease patients and healthy subjects are shown in Table 3. Most of the elements exhibited a broad range of concentrations. However, on an average basis, predominantly higher levels were noted for Fe (470000 μg/L), Ca (88900 μg/L) and Mg (39900 μg/L), followed by comparatively lower concentrations of Zn (4550 μg/L), Cu (1170 μg/L) and Pb (58.10 μg/L) in the blood of the patients. Nevertheless, the lowest concentrations were found for Cd and Co. On an average basis, the decreasing trend of elemental levels in the blood of the coronary artery disease patients revealed the following order: Fe > Ca > Mg > Zn > Cu > Pb > Mn > Cr > Co > Cd. The distribution of Fe, Ca and Mg was relatively random as shown by higher SD; however, considerably higher values of skewness for Ca, Mg, Mn and Zn evidenced their asymmetric distribution in blood of the patients.

Table 3. Statistical distribution parameters for selected element concentrations (μg/L) in blood of coronary artery disease patients and healthy donors .

CAD patients Healthy donors *p-value #p-value
Range Mean Median SD Skew Range Mean Median SD Skew
Ca 11100-582000 88900 56700 51100 3.230 15200-240000 70000 60000 44800 2.140 0.049 0.455
Mg 13700-162500 39900 33600 25300 3.690 13500-133000 35400 30700 20400 3.130 0.492 0.627
Fe 250000-734000 470000 486000 117000 0.045 156000-861000 375000 354000 137000 1.370 0.016 0.001
Zn 1230-11900 4550 4310 2230 1.640 1040-11200 4930 4770 2150 0.840 0.432 0.867
Cu 340-1730 1170 1260 402 -0.440 210-1940 902 820 430 0.790 0.021 0.003
Co 0.113-1.680 0.690 0.633 0.392 0.340 0.050-1.440 0.570 0.513 0.380 0.500 0.127 0.153
Mn 0.380-69.80 7.100 3.740 13.60 3.760 0.330-44.60 5.640 3.720 7.796 3.830 0.041 0.733
Cr 0.070-4.640 1.630 1.687 1.157 0.780 0.033-2.730 0.790 0.684 0.668 1.130 0.0005 0.0004
Cd 0.042-1.480 0.550 0.430 0.381 0.640 0.034-1.290 0.450 0.402 0.273 1.240 0.447 0.732
Pb 0.420-150.0 58.10 53.80 47.14 0.190 2.860-143.0 39.20 19.63 28.68 1.300 0.001 0.0008

* For comparison of mean levels (t-test); # For comparison of median levels (Wilcoxon rank sum test). CAD, coronary artery disease.

In the case of controls (Table 3), predominantly higher mean levels were shown by Fe (375000 μg/L), Ca (70000 μg/L) and Mg (35400 μg/L), followed by relatively lower concentration of Zn (4930 μg/L), Cu (902 μg/L) and Pb (39.20 μg/L). The distribution of Fe, Ca and Mg was mostly random, whereas the rest of the elements exhibited a lower degree of randomness. Higher skewness values for Mn, Mg and Ca indicated their asymmetrical distribution in blood of the controls. On the mean scale, a decreasing trend of the elements in blood of controls revealed the following order: Fe > Ca > Mg > Zn > Cu > Pb > Mn > Cr > Co > Cd (Table 3). Overall, a similar decreasing trend of the elemental levels in blood of the patients and controls was observed in this study. A systematic and detailed comparison (two sample t-test) of the mean concentrations of the elements measured in the blood of the patients and healthy donors manifested that average concentrations of Pb and Cr were found to be significantly higher in the blood of coronary artery disease patients (p < 0.001), while mean levels of Fe, Ca, Cu and Mn were observed to be moderately higher in blood of the patients (p < 0.05). However, statistically non-significant differences at p < 0.05 were found for mean values of Zn, Mg, Co and Cd in blood of the patients and controls. Similarly, median concentrations of the elements were also compared by Wilcoxon rank sum test which revealed statistically significant differences (p < 0.05) for Cr, Pb, Fe and Cu in the blood samples of two groups.

Several epidemiological studies revealed the fact that the disruption of elemental homeostasis, especially redox-active elements, may lead to uncontrolled elemental-mediated formation of deleterious free radicals participating in the modifications to DNA bases, enhanced lipid peroxidation and altered metabolic activities of enzymatic systems.23 Iron and copper belong to the category of such redox-active elements. They are vital for life and can be toxic when present in excess. The free redox iron and copper in the body generates damaging reactive free radicals via Fenton chemistry. These deleterious free radicals stimulate the lipid peroxidation, especially LDL, and ultimately lead to subsequent tissue damage. LaMarca et al. in a study showed that elevated iron levels are responsible for the production of reactive oxygen species (ROS) which can predispose to coronary disease and myocardial infarction.24 Furthermore, a significant correlation between iron catalyzed lipid peroxidation and protein peroxidation/atherosclerosis was reported in the study of de Valk and Marx.25 These iron and copper generated ROS are involving in the promotion of atherogenesis and prothrombotic events. Along with LDL, cardioprotective high density lipoprotein (HDL) is also susceptible to oxidation. HDL is more sensitive to oxidation by copper than LDL.3 In the present study, Fe and Cu showed markedly higher levels in the blood of patients, which supported the above toxic role of these two redox-active metals in the development of coronary artery disease (Table 3).

Cadmium is not directly involved in free radicals production, however indirect formation of ROS and reactive nitrogen species (RNS) involving the superoxide radical, hydroxyl radical and nitric oxide has been reported. Cadmium-induced toxicity can be explained on the basis of its ability to displace the copper and iron from their binding sites, and as a result free iron and copper is available for the generation of ROS via the Fenton reaction.26 This free radical-induced endothelial dysfunction accelerates atherosclerotic plaque formation and interferes with the antioxidant mechanism.27 It may also contribute to atherosclerosis by increasing blood pressure.2,28 But the exact role of Cd in the alteration of metabolism is still not clear.

Calcium deposition in the arteries plays a critical role in the atherosclerotic plaque formation which is the main cause of coronary artery disease. Cholesterol and its oxidation products along with other risk factors like hypertension and smoking may accelerate coronary calcification.29 Furthermore, increased intracellular calcium may damage the function of endothelial cells, resulting in platelet aggregation at the damaged site. This increase in the amounts of calcium has been shown to be present in noncomplex, lipid-rich fibromuscular plaques and is best correlated with severity of stenosis of the artery.30,31 In the present study, Ca concentration was found to be significantly higher in patients compared to the healthy subjects (Table 3), which is consistent with the above-mentioned hypothesis. In coronary artery disease episodes due to coronary artery spasm, treatment with magnesium has been shown to be considerably efficacious.32 But epidemiological studies have yielded mixed results about the efficacy of magnesium in the secondary prevention of cardiovascular disease.33 In this study, Mg levels did not exhibit any considerable difference in both categories of donors (Table 3).

Lead is a toxic element to humans and has multifactorial pathogenetic effects.34 It directly interrupts the activity of enzymes, competitively inhibits absorption of important trace minerals and deactivates antioxidant sulphydryl pools. It may induce free radical damage via two ways; the first way involves the direct formation of ROS including singlet oxygen, hydroperoxides and hydrogen peroxides, and the second mechanism is achieved via depletion of the cellular antioxidant pool.35,36 It has been reported that the changes in lipid profile in lead-exposed individuals showed coexistence with other risk factors towards heart diseases.37 In the present study, Pb level was noted to be higher in patients, which underscores its toxic contribution towards the progression or development of coronary artery disease (Table 3).

Zinc is an essential component of more than 70 different enzymes which are involved in the regulation of several cellular metabolic activities, including the metabolism of different proteins, lipids and carbohydrates in the human body. Antagonistic to the redox-active elements, Zn may serve as an antioxidant agent. Its antioxidant activities involve the protection of sulphydryl groups of proteins against free radical attack and the reduction of free radical formation through prevention mechanisms.3,38 Furthermore, Zn is an anti-inflammatory and maintains the integrity of endothelial cells which prevent the development of atherosclerosis.39 Cobalt is rarely associated with the development of heart disease but its acute toxicity may in part manifest through accumulation in the myocardium.40 In Table 3, a non-significant difference was observed in the Co levels in both donor groups, which revealed that Co is not directly or independently associated with the development of heart disease. Thus, the foregoing discussion clearly showed that the relative distribution of the elements in the blood of patients with coronary artery disease is appreciably different than those observed in blood of healthy subjects, which also pointed out the specific role of the elements in the development of the disease.

Correlation study

Table 4 shows the Spearman correlation coefficients (r) between selected elements in the blood of patients and controls, wherein significant r-values are shown in bold at p ≤ 0.01. In the case of patients, significantly strong correlations were noted between Mg-Mn (r = 0.903), Ca-Mn (r = 0.860), Ca-Mg (r = 0.776), Mg-Fe (r = 0.678), Mg-Cu (r = 0.660), Zn-Cu (r = 0.651), Cr-Mn (r = 0.601), Zn-Mn (r = 0.579), Pb-Cu (r = 0.565), Co-Cd (r = 0.556) and Fe-Cr (r = 0.532). Thus, toxic elements revealed mutual associations with the essential elements in blood of the patients, which may be associated with the disorder. On the other hand, Pb-Cd showed significant negative correlation (r = -0.481) in the blood of patients. In the cases of healthy subjects, strong mutual correlations were observed between Ca-Mg (r = 0.839), Zn-Mg (r = 0.700), Mg-Mn (r = 0.668), Zn-Fe (r = 0.649), Ca-Cu (r = 0.582), Ca-Mn (r = 0.560), Fe-Mn (r = 0.548), Fe-Cu (r = 0.531), Co-Cr (r = 0.526) and Zn-Ca (r = 0.520). Therefore, unlike the patients, most of the essential elements (Ca, Mg, Zn, Fe and Cu) exhibited significant mutual relationships in the blood of controls. Nonetheless, Cd manifested a significantly inverse relationship with Fe (r = -0.420) in the blood of the controls, while Pb displayed insignificant relationships with other elements. The correlation findings that were observed in the blood of patients were considerably diverse from those observed in blood of the healthy subjects.

Table 4. Correlation coefficient (r)* matrix of selected elements in blood of coronary artery disease patients (below the diagonal) and healthy donors (above the diagonal) .

Healthy donors
Ca Mg Fe Zn Cu Co Mn Cr Cd Pb
CAD patients Ca 1 0.839 0.409 0.520 0.582 -0.201 0.560 0.352 -0.152 -0.046
Mg 0.776 1 0.097 0.700 0.259 0.201 0.668 -0.063 0.157 -0.061
Fe 0.066 0.678 1 0.649 0.531 -0.110 0.548 0.109 -0.420 0.285
Zn -0.113 -0.029 0.445 1 0.154 -0.294 -0.131 -0.006 -0.225 0.108
Cu 0.206 0.660 0.418 0.651 1 0.063 0.467 0.046 -0.292 -0.164
Co 0.186 -0.147 0.276 0.129 0.149 1 -0.027 0.526 -0.013 0.163
Mn 0.860 0.903 0.117 0.579 0.342 0.236 1 -0.022 0.051 0.071
Cr 0.136 0.420 0.532 0.495 0.467 -0.073 0.601 1 -0.100 0.185
Cd 0.019 -0.100 0.199 0.237 0.055 0.556 0.061 0.338 1 0.067
Pb -0.033 -0.203 0.469 0.029 0.565 0.152 0.006 0.212 -0.481 1

* Bold r-values are significant at p ≤ 0.05.

Comparison of the elemental levels based on demographic characteristics

Variations in the average concentrations of selected elements [±standard deviation (SD)] in the blood of coronary artery disease patients and controls based on gender, abode, food habits and smoking habits are shown in Table 5. In the case of gender-based comparison, mean concentrations of Mn showed significantly higher levels (p < 0.001), along with a considerable rise (p < 0.05) in the Ca and Mg mean levels in blood of male patients than female patients. On the contrary, Ca and Mg levels were noted to be appreciably higher (p < 0.05) in female controls. However, the average levels of Cd and Pb in male controls exhibited the opposite trend and showed noticeably elevated levels (p < 0.05). The rest of the elements showed non-significant differences in the blood of male and female donors.

Table 5. Comparison of the average concentrations of selected elements (mean ± SD) in blood of the coronary artery disease patients and controls based on gender, abode, food habits and smoking habits .

Ca Mg Fe Zn Cu Co Mn Cr Cd Pb
Female patients 72400 ± 42300 34100 ± 16400 485000 ± 80600 4500 ± 2100 1120 ± 890 0.642 ± 0.510 3.464 ± 1.765 1.641 ± 0.851 0.507 ± 0.210 57.35 ± 30.22
Male patients 99100 ± 53400 43400 ± 19600 460800 ± 78200 4600 ± 1960 1200 ± 940 0.725 ± 0.481 9.407 ± 7.152 1.621 ± 0.789 0.581 ± 0.254 58.61 ± 25.27
*p-value 0.038 0.041 0.824 0.921 0.874 0.751 0.0003 0.867 0.810 0.748
Female controls 79500 ± 52300 42000 ± 17900 418700 ± 76800 5260 ± 2600 893 ± 650 0.602 ± 0.572 5.641 ± 3.970 0.843 ± 0.321 0.381 ± 0.183 34.13 ± 15.22
Male controls 61800 ± 33900 30700 ± 11600 352800 ± 69700 4780 ± 2150 892 ± 360 0.570 ± 0.420 5.575 ± 3.420 0.745 ± 0.304 0.498 ± 0.167 44.29 ± 18.77
*p-value 0.044 0.047 0.624 0.736 0.951 0.685 0.813 0.705 0.046 0.047
Rural patients 110500 ± 74600 44700 ± 21300 493200 ± 112400 4660 ± 1870 1140 ± 820 0.618 ± 0.484 7.000 ± 5.310 1.747 ± 0.752 0.576 ± 0.216 44.59 ± 20.47
Urban patients 79700 ± 52800 37800 ± 17200 460100 ± 106700 4510 ± 1690 1180 ± 730 0.727 ± 0.471 7.147 ± 5.043 1.578 ± 0.410 0.543 ± 0.227 63.93 ± 23.18
*p-value 0.029 0.314 0.442 0.724 0.810 0.773 0.802 0.462 0.754 0.009
Rural controls 86400 ± 45700 40640 ± 18400 349700 ± 95300 5100 ± 2160 1125 ± 760 0.641 ± 0.364 2.481 ± 2.014 0.823 ± 0.542 0.314 ± 0.116 21.50 ± 11.65
Urban controls 65800 ± 30900 34530 ± 12300 388500 ± 98600 4970 ± 1580 842 ± 190 0.572 ± 0.310 6.287 ± 2.837 0.780 ± 0.442 0.476 ± 0.165 43.87 ± 19.20
*p-value 0.028 0.161 0.520 0.791 0.019 0.663 0.0007 0.581 0.009 0.0006
N-Veg. patients 107300 ± 69500 36600 ± 20400 487800 ± 124700 4800 ± 1940 1260 ± 500 0.659 ± 0.411 7.771 ± 5.812 1.952 ± 0.950 0.518 ± 0.193 64.62 ± 28.51
Vegetarian patients 78600 ± 46100 41700 ± 21800 460000 ± 116200 4410 ± 1810 1110 ± 480 0.713 ± 0.397 6.715 ± 4.920 1.447 ± 0.641 0.570 ± 0.185 55.35 ± 25.01
*p-value 0.037 0.305 0.427 0.503 0.661 0.390 0.220 0.041 0.916 0.097
N-Veg. controls 73350 ± 35600 36150 ± 16200 369600 ± 88400 4800 ± 2230 855 ± 310 0.480 ± 0.295 3.485 ± 1.823 0.591 ± 0.305 0.382 ± 0.092 36.24 ± 21.05
Vegetarian controls 66840 ± 21600 35260 ± 15700 389900 ± 91300 5120 ± 2530 919 ± 550 0.657 ± 0.250 7.108 ± 4.810 0.925 ± 0.455 0.500 ± 0.152 42.07 ± 20.67
*p-value 0.116 0.317 0.441 0.528 0.160 0.031 0.0005 0.006 0.038 0.137
N-Smok. patients 68000 ± 37200 34300 ± 13500 464500 ± 77600 4380 ± 2050 1120 ± 440 0.738 ± 0.455 3.525 ± 1.760 1.579 ± 0.710 0.566 ± 0.210 57.63 ± 30.20
Smoking patients 105400 ± 61900 44200 ± 16100 474400 ± 81500 4690 ± 2160 1206 ± 450 0.659 ± 0.462 10.02 ± 6.271 1.667 ± 0.682 0.542 ± 0.251 58.52 ± 26.31
*p-value 0.008 0.025 0.350 0.286 0.163 0.521 0.0004 0.273 0.861 0.722
N-Smok. controls 76700 ± 29500 39380 ± 20700 397300 ± 84900 5090 ± 2300 900 ± 370 0.515 ± 0.337 5.639 ± 3.045 0.713 ± 0.341 0.368 ± 0.142 32.03 ± 16.37
Smoking controls 60200 ± 24800 30760 ± 15600 361200 ± 80800 4860 ± 2160 882 ± 330 0.673 ± 0.325 5.559 ± 2.866 0.884 ± 0.382 0.563 ± 0.211 49.69 ± 22.14
*p-value 0.029 0.021 0.273 0.490 0.557 0.043 0.790 0.668 0.008 0.007

* p-value for two sample t-test.

In habitat-based comparisons (Table 5), only the average concentration of Ca was considerably higher (p < 0.05) in the blood of the rural patients, while the mean level of Pb was markedly higher (p < 0.01) in the blood of the urban patients. However, rural controls showed considerable elevation (p < 0.05) in mean levels of Ca and Cu, whereas, Mn, Pb and Cd revealed significantly elevated levels in blood of urban controls. The rest of the elements showed almost equivalent mean levels in both categories.

As shown in Table 5, the mean levels of Ca and Cr exhibited appreciably higher concentrations (p < 0.05) in the blood of non-vegetarian patients than vegetarian patients, while other elements exhibited insignificant variation in their mean levels. Likewise, vegetarian controls showed significantly elevated mean levels (p < 0.01) of Mn and Cr, followed by considerably higher (p < 0.05) Co and Cd concentrations.

A comparison of average elemental concentrations in the blood of patients and controls based on their smoking habits is also displayed in Table 5. The mean levels of Mn and Ca were significantly higher (p < 0.01) in the blood of patients with smoking habits, followed by a moderately higher (p < 0.05) concentration of Mg. Nonetheless, the mean concentrations of Fe, Zn, Cu, Co, Cr, Cd and Pb were more or less comparable in the blood of the smoker and non-smoker patients. In case of controls, relatively higher contents of Ca and Mg were noted in the blood of non-smoking subjects (p < 0.05), while significant elevated mean levels (p < 0.01) of Cd and Pb, along with appreciably higher (p < 0.05) concentrations of Co were found in the blood of the smoking subjects.

Multivariate apportionment

Another important aspect of the present study was multivariate apportionment of the elements using cluster analyses.22 The dendrogram of the elements in patient blood samples is shown in Figure 1(A), which showed strong mutual clusters among Mg-Mn-Ca-Co-Cd and Cu-Pb-Fe-Zn-Cr. The former group of elements was mainly contributed by dietary sources whereas the latter was primarily contributed by the anthropogenic activities and regulated by internal body metabolism. One of the advantages of multivariate CA is that it showed multiple mutual associations among the elements which are not so apparent in univariate methods such as correlation analysis. In the case of the first cluster, Cd and Co showed significant associations with Ca, Mg and Mn, thus indicating their mutual variations in the patients. Moreover, CA revealed that redox-active elements (Cu and Fe) and elements with accumulative property (Ca and Cd) shared common clusters with the essential minerals, thus indicating their critical role in the development of coronary artery disease. Numerous epidemiological studies established the role of these elements in the development of cardiovascular diseases (CVD); LaMarca et al., de Valk and Marx, Kazi et al., and Hemelrijck et al. in their separate studies all discussed the proposed mechanisms of these elements towards the progression of CVD.7,24,25,29 In case of the healthy subjects, cluster analysis in the form of dendrogram is shown in Figure 1(B), which revealed very strong clusters of Ca-Mg-Cu-Zn, Cr-Mn-Fe and Co-Cd-Pb. Interestingly, most of the toxic elements shared common clusters, while most of the essential elements exhibited mutual associations and evidenced the true picture of normal elemental metabolism in the human body, which was significantly diverse compared to the patients. Consequently, multivariate cluster analysis of the elements in blood has the potential application to be used as an additional tool for the diagnosis/prognosis of the disease.

Figure 1.

Figure 1

Cluster analyses of selected trace elements in blood of coronary artery disease patients and healthy donors.

CONCLUSIONS

In conclusion, the present study provided evidence of marked disparities in the distribution of essential and toxic elements in blood of coronary artery disease patients compared with healthy subjects. Significantly higher concentrations of Pb, Cr, Cu, Fe, Ca and Mn were observed in the blood of CAD patients than in controls. Some noteworthy variations were also observed in the blood elemental levels based on gender, habitat, food habits and smoking habits of the subjects in both groups. The correlation study revealed appreciably different mutual variations of trace elements in blood of the patients as well as the controls. Multivariate CA exhibited diverse apportionment of the essential and toxic elements in the blood of coronary artery disease patients and healthy donors which evidenced the role of the selected elements imbalance in the development of the disease. The statistical mode of elemental analysis in the present study may be used as an additional tool for the prediction and progression of the disease.

Acknowledgments

Funding that was provided by the Higher Education Commission, Government of Pakistan, to carry out this project is thankfully acknowledged. We are also grateful to the administration of the Punjab Institute of Cardiology, Lahore, Pakistan for their invaluable help during sample collection. Technical and financial help by Quaid-i-Azam University, Islamabad, Pakistan to execute this project is also acknowledged.

CONFLICTS OF INTEREST

None.

REFERENCES

  • 1. Alissa EM, Bahjri SM, Ahmed WH, et al. Trace element status in Saudi patients with established atherosclerosis. J Trace Elem Med Bio. 2006;20:105–114. doi: 10.1016/j.jtemb.2005.10.004. [DOI] [PubMed] [Google Scholar]
  • 2. Tellez-Plaza M, Jones MR, Dominguez-Lucas A, et al. Cadmium exposure and clinical cardiovascular disease: a systematic review. Curr Atheroscler Rep. 2013;15:356. doi: 10.1007/s11883-013-0356-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Jomova K, Valko M. Review: advances in metal-induced oxidative stress and human disease. Toxicology. 2011;283:65–87. doi: 10.1016/j.tox.2011.03.001. [DOI] [PubMed] [Google Scholar]
  • 4. Genuis SJ, Birkholz D, Rodushkin I, Beesoon S. Blood, urine, and sweat (bus) study: monitoring and elimination of bioaccumulated toxic elements. Arch Environ Con Tox. 2011;61:344–357. doi: 10.1007/s00244-010-9611-5. [DOI] [PubMed] [Google Scholar]
  • 5. Eby GA, Halcomb WW. High-dose zinc to terminate angina pectoris: a review and hypothesis for action by ICAM inhibition. Med Hypotheses. 2006;66:169–172. doi: 10.1016/j.mehy.2005.06.013. [DOI] [PubMed] [Google Scholar]
  • 6. Rubbo H, O’Donnell V. Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanism insights. Toxicology. 2005;208:305–317. doi: 10.1016/j.tox.2004.11.019. [DOI] [PubMed] [Google Scholar]
  • 7. Kazi TG, Afridi HI, Kazi N, et al. Distribution of zinc, copper and iron in biological samples of Pakistani myocardial infarction (1st, 2nd and 3rd heart attack) patients and controls. Clin Chim Acta. 2008;389:114–119. doi: 10.1016/j.cca.2007.12.004. [DOI] [PubMed] [Google Scholar]
  • 8. Tellez-Plaza M, Navas-Acien A, Crainiceanu CM, Guallar E. Cadmium exposure and hypertension in 1999-2004 national health and nutrition examination survey (NHANES) Environ Health Perspect. 2008;116:51–56. doi: 10.1289/ehp.10764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Standstead HH, Klevay LM. History of nutrition symposium: trace element nutrition and human health. J Nutr. 2000;130:483–484. doi: 10.1093/jn/130.2.483S. [DOI] [PubMed] [Google Scholar]
  • 10. Agarwal S, Zaman T, Tuzcu EM, Kapadia SR. Heavy metals and cardiovascular disease: results from the national health and nutrition examination survey (NHANES) Angiology. 2011;65:422–429. doi: 10.1177/0003319710395562. [DOI] [PubMed] [Google Scholar]
  • 11. Saghir M, Shaheen N, Shah MH. Comparative evaluation of trace metals in the blood of hepatitis-C patients and healthy donors. Biol Trace Elem Res. 2011;143:751–763. doi: 10.1007/s12011-010-8930-8. [DOI] [PubMed] [Google Scholar]
  • 12. Pasha Q, Malik SA, Shaheen N, Shah MH ,. Investigation of trace metals in the blood plasma and scalp hair of gastrointestinal cancer patients in comparison with controls. Clin Chim Acta. 2010;411:531–539. doi: 10.1016/j.cca.2010.01.010. [DOI] [PubMed] [Google Scholar]
  • 13. Zhao TT, Chen B, Wang HP, et al. Evaluation of toxic and essential elements in whole blood from 0- to 6-year-old children from Jinan, China. Clin Biochem. 2013;46:612–616. doi: 10.1016/j.clinbiochem.2013.02.007. [DOI] [PubMed] [Google Scholar]
  • 14. Brettell TA, Butler JM, Saferstein R. Forensic science. Anal Chem. 2005;77:3839–3860. doi: 10.1021/ac050682e. [DOI] [PubMed] [Google Scholar]
  • 15. Pamphlett R, McQuilty R, Zarkos K. Blood levels of toxic and essential metals in motor neuron disease. Neurotoxicology. 2001;22:401–410. doi: 10.1016/s0161-813x(01)00029-8. [DOI] [PubMed] [Google Scholar]
  • 16. Marroquin OC, Kip KE, Kelley DE, et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women a report from the women’s ischemia syndrome evaluation. Circulation. 2004;109:714–721. doi: 10.1161/01.CIR.0000115517.26897.A7. [DOI] [PubMed] [Google Scholar]
  • 17. Afridi HI, Kazi TG, Kazi N, et al. Evaluation of toxic elements in scalp hair samples of myocardial infarction patients at different stages as related to controls. Biol Trace Elem Res. 2010;134:1–12. doi: 10.1007/s12011-009-8450-6. [DOI] [PubMed] [Google Scholar]
  • 18. Aitio A, Jarvisalo J. Trace element analysis in biological samples. Amsterdam : Elsevier Science ; 1994. Sampling and sample storage. In: Heber RFM, Stoeppler M, editors; pp. 21– 52. [Google Scholar]
  • 19. Bowen RAR, Hortin GL, Csako G, et al. Impact of blood collection devices on clinical chemistry assays. Clin Biochem. 2010;43:4–25. doi: 10.1016/j.clinbiochem.2009.10.001. [DOI] [PubMed] [Google Scholar]
  • 20. Sansoni B, Panday VK. Trace element analysis in biological samples. Amsterdam : Elsevier Science; 1994. Sample treatment of human biological materials. In: Herber RFM, Stoeppler M, editors. [Google Scholar]
  • 21. StatSoft Inc. STATISTICA for Windows. Tulsa: OK; 1999. Computer program manual. [Google Scholar]
  • 22. Jobson JD. Applied multivariate data analysis. New York: Springer; 1991. [Google Scholar]
  • 23. Jomova K, Baros S, Valko M. Redox active metal-induced oxidative stress in biological systems. Transit Met Chem. 2012;37:127–134. [Google Scholar]
  • 24. LaMarca BD, Gilbert J, Granger JP. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension. 2008;51:982–988. doi: 10.1161/HYPERTENSIONAHA.107.108837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. de Valk B, Marx JJ. Iron, atherosclerosis and ischemic heart disease. Arch Intern Med. 1999;159:1542–1548. doi: 10.1001/archinte.159.14.1542. [DOI] [PubMed] [Google Scholar]
  • 26. Waalkes MP. Cadmium carcinogenesis in review. J Inorg Biochem. 2000;79:241–244. doi: 10.1016/s0162-0134(00)00009-x. [DOI] [PubMed] [Google Scholar]
  • 27. Messner B, Knoflach M, Seubert A, et al. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol. 2009;29:1392–1398. doi: 10.1161/ATVBAHA.109.190082. [DOI] [PubMed] [Google Scholar]
  • 28. Gallagher CM, Meliker JR. Blood and urine cadmium, blood pressure, and hypertension: a systematic review and meta-analysis. Environ Health Perspect. 2010;118:1676–1684. doi: 10.1289/ehp.1002077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Hemelrijck MV, Michaelsson K, Linseisen J, Rohrmann S. Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III. PLOS ONE. 2013;8:e61037. doi: 10.1371/journal.pone.0061037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Rumberger JA, Schwartz RS, Simons DB, et al. Relations of coronary calcium determined by electron beam computed tomography and lumen narrowing determined at autopsy. Am J Cardiol. 1994;73:1169–1173. doi: 10.1016/0002-9149(94)90176-7. [DOI] [PubMed] [Google Scholar]
  • 31. Tulenko TN, Kleintop LL, Walter MF, Mason RP. Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection? Int J Cardiol. 1997;62:55–66. doi: 10.1016/s0167-5273(97)00242-8. [DOI] [PubMed] [Google Scholar]
  • 32. McLean RM. Magnesium and its therapeutic uses: a review. Am J Med. 1994;96:63–76. doi: 10.1016/0002-9343(94)90117-1. [DOI] [PubMed] [Google Scholar]
  • 33. Gobbo LC, Imamura F, Wu JH, et al. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2013;98:160–173. doi: 10.3945/ajcn.112.053132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Poreba R, Gac P, Porebab M, Andrzejak R. Environmental and occupational exposure to lead as a potential risk factor for cardiovascular disease. Environ Toxicol Phar. 2011;3:267–277. doi: 10.1016/j.etap.2010.12.002. [DOI] [PubMed] [Google Scholar]
  • 35. Hsu PC, Guo YL. Antioxidant nutrients and lead toxicity. Toxicology. 2002;180:33–44. doi: 10.1016/s0300-483x(02)00380-3. [DOI] [PubMed] [Google Scholar]
  • 36. Patrick L. Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern Med Rev. 2006;11:114–127. [PubMed] [Google Scholar]
  • 37. Skoczyn´ ska A, Gruber K, Belowska-Bien K, Mlynek V. Risk of cardiovascular diseases in lead-exposed workers of crystal glassworks, part I. Effect of lead on blood pressure and lipid metabolism. Med Pr. 2007;58:475–483. [PubMed] [Google Scholar]
  • 38. Pepersack T, Rotsaert P, Benoit F, et al. Prevalence of zinc deficiency and its clinical relevance among hospitalised elderly. Arch Gerontol Geriat. 2001;33:243–253. doi: 10.1016/s0167-4943(01)00186-8. [DOI] [PubMed] [Google Scholar]
  • 39. Little PJ, Bhattacharya R, Moreyra AE, Korichneva IL. Zinc and cardiovascular disease. Nutrition . 2010;26:1050–1057. doi: 10.1016/j.nut.2010.03.007. [DOI] [PubMed] [Google Scholar]
  • 40. Simonsen LO, Harbak H, Bennekou P. Cobalt metabolism and toxicology — a brief update. Sci Total Environ. 2012;432:210–215. doi: 10.1016/j.scitotenv.2012.06.009. [DOI] [PubMed] [Google Scholar]

Articles from Acta Cardiologica Sinica are provided here courtesy of Taiwan Society of Cardiology

RESOURCES